National databases and rheumatology research I: Longitudinal databases in Scandinavia

Rheumatic Disease Clinics of North America

Volumn 30, Issue 4, 2004, Pages 851-867

  Sokka, Tuulikki ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

CANCER REGISTRY; CLINICAL TRIAL; DATA BASE; HOSPITAL DISCHARGE; HUMAN; MEDICAL RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCANDINAVIA; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS;

DATABASES; HUMANS; LONGITUDINAL STUDIES; REGISTRIES; RESEARCH DESIGN; RHEUMATIC DISEASES; SCANDINAVIA;

EID: 5444255747     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2004.07.002     Document Type: Review

References (86)

1. The Bible. Luke 2:1-3
2. J.P. Vandenbroucke Maintaining privacy and the health of the public. Should not be seen as in opposition BMJ 316 7141 1998 1331 1332
3. H. Saul Privacy and cancer registries in Europe Eur J Cancer 38 1 2002 3
4. T. Bjerkedal Protection of privacy against protection of health Acta Obstet Gynecol Scand 79 6 2000 520 522
5. E. Pukkala Use of record linkage in small-area studies P. Elliot J. Guzick D. English R. Stern Geographical and environmental epidemiology 1992 Oxford University Press Oxford (UK) 125 131
6. L. Teppo, E. Pukkala, and M. Lehtonen Data quality and quality control of a population-based cancer registry. Experience in Finland Acta Oncol 33 4 1994 365 369
7. B. Mattsson, and A. Wallgren Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978 Acta Radiol Oncol 23 5 1984 305 313
8. National Agency for Medicines (Finland) Available at: http://www.nam.fi/english/information/consumption/index.html Accessed April 2004
9. H. Gudmundsson, D.F. Gudbjartsson, M. Frigge, J.R. Gulcher, and K. Stefansson Inheritance of human longevity in Iceland Eur J Hum Genet 8 10 2000 743 749
10. S.F. Grant, G. Thorleifsson, M.L. Frigge, J. Thorsteinsson, B. Gunnlaugsdottir, and A.J. Geirsson The inheritance of rheumatoid arthritis in Iceland Arthritis Rheum 44 10 2001 2247 2254
11. M. Lambe, L. Bjornadal, P. Neregard, O. Nyren, and G.S. Cooper Childbearing and the risk of scleroderma: a population-based study in Sweden Am J Epidemiol 159 2 2004 162 166
12. M. Lehtinen, P. Koskela, H.M. Ogmundsdottir, A. Bloigu, J. Dillner, and M. Gudnadottir Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring Am J Epidemiol 158 3 2003 207 213
13. E. Jellum, A. Andersen, P. Lund-Larsen, L. Theodorsen, and H. Orjasaeter Experiences of the Janus Serum Bank in Norway Environ Health Perspect 103 Suppl 3 1995 85 88
14. P. Koskela, T. Anttila, T. Bjorge, A. Brunsvig, J. Dillner, and M. Hakama Chlamydia trachomatis infection as a risk factor for invasive cervical cancer Int J Cancer 85 1 2000 35 39
15. The National Biobank Program Available at: http://www.biobanks.se Accessed April 2004
16. M. Lehtinen, P. Koskela, E. Jellum, A. Bloigu, T. Anttila, and G. Hallmans Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the Nordic countries Am J Epidemiol 156 8 2002 687 692
17. P. Tuohimaa, L. Tenkanen, M. Ahonen, S. Lumme, E. Jellum, and G. Hallmans Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries Int J Cancer 108 1 2004 104 108
18. H.A. Isomäki, O. Mutru, and K. Koota Death rate and causes of death in patients with rheumatoid arthritis Scand J Rheumatol 4 1975 205 208
19. K. Koota, H. Isomäki, and O. Mutru Death rate and causes of death in RA patients during a period of five years Scand J Rheumatol 6 1977 241 244
20. S. Cobb, F. Anderson, and W. Bauer Length of life and cause of death in rheumatoid arthritis N Engl J Med 249 1953 553 556
21. J.J.R. Duthie, P.E. Brown, L.H. Truelove, F.D. Baragar, and A.J. Lawrie Course and prognosis in rheumatoid arthritis: a further report Ann Rheum Dis 23 1964 193 204
22. J. Uddin, A.S. Kraus, and H.G. Kelly Survivorship and death in rheumatoid arthritis Arthritis Rheum 13 1970 125 130
23. T.G. Reah The prognosis of rheumatoid arthritis (185 patients followed up over 13 years) Proc R Soc Med 56 1963 813 817
24. O. Mutru, M. Laakso, H. Isomäki H, Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis BMJ 290 1985 1811 1813
25. R. Myllykangas-Luosujärvi, K. Aho, H. Kautiainen, and H. Isomäki Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis Clin Exp Rheumatol 13 1995 149 153
26. R. Myllykangas-Luosujarvi, K. Aho, H. Kautiainen, and H. Isomaki Cardiovascular mortality in women with rheumatoid arthritis J Rheumatol 22 6 1995 1065 1067
27. R. Myllykangas-Luosujarvi, K. Aho, and H. Isomaki Mortality from cancer in patients with rheumatoid arthritis Scand J Rheumatol 24 2 1995 76 78
28. R. Myllykangas-Luosujärvi, K. Aho, and H. Isomäki Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died J Rheumatol 22 1995 2214 2217
29. P. Allebeck, A. Ahlbom, and E. Allander Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate: eleven year follow-up of an epidemiological study Scand J Rheumatol 10 1981 301 306
30. P. Allebeck Increased mortality in rheumatoid arthritis Scand J Rheumatol 11 1982 81 86
31. S. Wållberg-Jonsson, H. Johansson, M. Öhman, and S. Rantapää-Dahlqvist Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset J Rheumatol 26 1999 2562 2571
32. E. Lindqvist, and K. Eberhardt Mortality in rheumatoid arthritis patients with disease onset in the 1980s Ann Rheum Dis 58 1999 11 14
33. L. Bjornadal, E. Baecklund, L. Yin, F. Granath, L. Klareskog, and A. Ekbom Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95 J Rheumatol 29 5 2002 906 912
34. K. Lehtinen Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis Ann Rheum Dis 52 1993 174 176
35. A. Savolainen, H. Kautiainen, H. Isomaki, R. Myllykangas-Luosujarvi, and K. Aho Age specific mortality in Finnish women with chronic inflammatory joint diseases during 1977-93 Ann Rheum Dis 56 12 1997 754
36. M.K. Söderlin, P. Nieminen, and M. Hakala Functional status predicts mortality in a community based rheumatoid arthritis population J Rheumatol 25 1998 1895 1899
37. T. Sokka, T. Möttönen, and P. Hannonen Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years Scand J Rheumatol 28 1999 282 287
38. A.G. Kvalvik, M.A. Jones, and D.P.M. Symmons Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992 Scan J Rheumatol 29 2000 29 37
39. T. Riise, B.K. Jacobsen, J.T. Gran, H.J. Haga, and E. Arnesen Total mortality is increased in rheumatoid arthritis. A 17-year prospective study Clin Rheumatol 20 2 2001 123 127
40. J.W. Wood, H. Kato, K.G. Johnson, Y. Uda, W.J. Russell, and I.F. Duff Rheumatoid arthritis in Hiroshima and Nagasaki, Japan: prevalence, incidence, and clinical characteristics Arthritis Rheum 10 1967 21 31
41. D.P.M. Symmons, E.M. Barrett, C.R. Bankhead, G.D.I. Scott, and A.J. Silman The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register Br J Rheumatol 33 1994 735 739
42. O. Kaipiainen-Seppänen, K. Aho, H. Isomäki, and M. Laakso Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during the 1975-1990 Clin Exp Rheumatol 14 1996 537 542
43. O. Kaipiainen-Seppanen, K. Aho, H. Isomaki, and M. Laakso Incidence of rheumatoid arthritis in Finland during 1980-1990 Ann Rheum Dis 55 9 1996 608 611
44. O. Kaipiainen-Seppänen, K. Aho, and M. Heliövaara Incidence and prevalence of ankylosing spondylitis in Finland J Rheumatol 24 1997 496 499
45. O. Kaipiainen-Seppanen Incidence of psoriatic arthritis in Finland Br J Rheumatol 35 12 1996 1289 1291
46. H.A. Isomäki, T. Hakulinen, and U. Joutsenlahti Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis J Chronic Dis 31 1978 691 696
47. T. Hakulinen, H. Isomäki, and P. Knekt Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland Am J Med 78 Suppl 1A 1985 29 32
48. M. Kauppi, E. Pukkala, and H. Isomaki Low incidence of colorectal cancer in patients with rheumatoid arthritis Clin Exp Rheumatol 14 5 1996 551 553
49. M. Kauppi, E. Pukkala, and H. Isomaki Excess risk of lung cancer in patients with rheumatoid arthritis J Rheumatol 23 8 1996 1484 1485
50. G. Gridley, J.K. McLaughlin, A. Ekbom, L. Klareskog, H.O. Adami, and D.G. Hacker Incidence of cancer among patients with rheumatoid arthritis J Natl Cancer Inst 85 4 1993 307 311
51. E. Baecklund, A. Ekbom, P. Sparen, N. Feltelius, and L. Klareskog Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study BMJ 317 7152 1998 180 181
52. E. Baecklund, C. Sundstrom, A. Ekbom, A.I. Catrina, P. Biberfeld, and N. Feltelius Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma Arthritis Rheum 48 6 2003 1543 1550
53. K. Ekstrom, H. Hjalgrim, L. Brandt, E. Baecklund, L. Klareskog, and A. Ekbom Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives Arthritis Rheum 48 4 2003 963 970
54. L. Bjornadal, B. Lofstrom, L. Yin, I.E. Lundberg, and A. Ekbom Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus Scand J Rheumatol 31 2 2002 66 71
55. L. Mellemkjaer, F. Alexander, and J.H. Olsen Cancer among children of parents with autoimmune diseases Br J Cancer 82 7 2000 1353 1357
56. A.M. Abdel-Nasser, J.J. Rasker, and H.A. Valkenburg Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis Semin Arthritis Rheum 27 1997 123 140
57. A.J. Silman, and J.E. Pearson Epidemiology and genetics of rheumatoid arthritis Arthritis Res 4 Suppl 3 2002 S265 S272
58. K. Aho, M. Koskenvuo, J. Tuominen, and J. Kaprio Occurrence of rheumatoid arthritis in a nationwide series of twins J Rheumatol 13 5 1986 899 902
59. A.J. Silman, A.J. MacGregor, W. Thomson, S. Holligan, D. Carthy, and A. Farhan Twin concordance rates for rheumatoid arthritis: results from a nationwide study Br J Rheumatol 32 1993 903 907
60. A.J. MacGregor, H. Snieder, A.S. Rigby, M. Koskenvuo, J. Kaprio, and K. Aho Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins Arthritis Rheum 43 1 2000 30 37
61. A.J. Svendsen, N.V. Holm, K. Kyvik, P.H. Petersen, and P. Junker Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population BMJ 324 7332 2002 264 266
62. A.J. Silman Commentary: do genes or environment influence development of rheumatoid arthritis? BMJ 324 7332 2002 264
63. T. Klaukka, and K. Kaarela Methotrexate is the leading DMARD in Finland Ann Rheum Dis 62 2003 494 496
64. P. Blomqvist, N. Feltelius, A. Ekbom, and L. Klareskog Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions J Clin Epidemiol 27 2000 1171 1177
65. A. Helin-Salmivaara, T. Klaukka, and R. Huupponen Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland Eur J Clin Pharmacol 59 5-6 2003 477 482
66. H.H. Holte, K. Tambs, and T. Bjerkedal Manual work as predictor for disability pensioning with osteoarthritis among the employed in Norway 1971-1990 Int J Epidemiol 29 3 2000 487 494
67. K.B. Hagen, H.H. Holte, K. Tambs, and T. Bjerkedal Socioeconomic factors and disability retirement from back pain: a 1983-1993 population-based prospective study in Norway Spine 25 19 2000 2480 2487
68. H.H. Holte, K. Tambs, and T. Bjerkedal Becoming a disability pensioner with rheumatoid arthritis in Norway 1971-1990 J Rheumatol 28 1 2001 54 61
69. K. Puolakka, H. Kautiainen, T. Möttönen, P. Hannonen, M. Korpela, and H. Julkunen Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis. A five-year randomized followup trial Arthritis Rheum 50 1 2004 55 62
70. A. Reunanen, A. Aromaa, K. Pyorala, S. Punsar, J. Maatela, and P. Knekt The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience Acta Med Scand Suppl 673 1983 1 120
71. M. Heliovaara, K. Aho, A. Aromaa, P. Knekt, and A. Reunanen Smoking and risk of rheumatoid arthritis J Rheumatol 20 11 1993 1830 1835
72. M. Heliovaara, K. Aho, P. Knekt, O. Impivaara, A. Reunanen, and A. Aromaa Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis Ann Rheum Dis 59 8 2000 631 635
73. P. Knekt, M. Heliovaara, K. Aho, G. Alfthan, J. Marniemi, and A. Aromaa Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis Epidemiology 11 4 2000 402 405
74. K. Aho, T. Palosuo, M. Heliovaara, P. Knekt, P. Alha, and R. von Essen Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion J Rheumatol 27 12 2000 2743 2746
75. K. Aho, T. Palosuo, P. Knekt, P. Alha, A. Aromaa, and M. Heliovaara Serum C-reactive protein does not predict rheumatoid arthritis J Rheumatol 27 5 2000 1136 1138
76. M. Heliövaara, K. Aho, P. Knekt, A. Aromaa, J. Maatela, and A. Reunanen Rheumatoid factor, chronic arthritis and mortality Ann Rheum Dis 54 1995 811 814
77. K. Aho, M. Heliovaara, K. Sievers, J. Maatela, and H. Isomaki Clinical arthritis associated with positive radiological and serological findings in Finnish adults Rheumatol Int 9 1 1989 7 11
78. T. Korpilahde, M. Heliovaara, O. Kaipiainen-Seppanen, P. Knekt, and K. Aho Regional differences in Finland in the prevalence of rheumatoid factor in the presence and absence of arthritis Ann Rheum Dis 62 4 2003 353 355
79. O. Kaipiainen-Seppanen, K. Aho, and M. Nikkarinen Regional differences in the incidence of rheumatoid arthritis in Finland in 1995 Ann Rheum Dis 60 2 2001 128 132
80. K. Aho, M. Heliövaara, J. Maatela, T. Tuomi, and T. Palosuo Rheumatoid factors antedating clinical rheumatoid arthritis J Rheumatol 18 1991 1282 1284
81. J.E. Moore, and W.B. Lutz The natural history of systemic lupus erythematosus: an approach to its study through chronic biologic false positive phenomenon J Chronic Dis 1 1955 297 316
82. K. Aho, P. Koskela, R. Makitalo, M. Heliovaara, and T. Palosuo Antinuclear antibodies heralding the onset of systemic lupus erythematosus J Rheumatol 19 9 1992 1377 1379
83. A. Aromaa S. Koskinen Health and functional capacity in Finland. Baseline results of the Health 2000 Health Examination Survey 2002 The National Public Health Institute Helsinki (Finland)
84. J. Vuorela, T. Sokka, E. Pukkala, and P. Hannonen Does yttrium radiosynovectomy increase the risk of cancer in patients with rheumatoid arthritis? Ann Rheum Dis 62 2003 251 253
85. T. Sokka, E. Krishnan, A. Häkkinen, and P. Hannonen Functional disability in rheumatoid arthritis patients compared with a community population in Finland Arthritis Rheum 48 1 2003 59 63
86. E. Krishnan, T. Sokka, and P. Hannonen Smoking-gender interaction and risk for rheumatoid arthritis Arthritis Res Ther 5 3 2003 R158 R162